Its just killing the stock. How much longer can management continue this? What’s to stop it from going into the teens? Im not bashing the stock but it goes down every week. There arent to many weeks left with this pace of decline. Les said no way he would do a R/S but what else can they do? Everybody nows including Les a R/S also hurts the shareholders. Just continue waiting while my Son who I got into the stock also looks at me like an idiot for ever telling him about the stock.
Biosectinvestor, Agree, swing trading is not helpful, to one's investment, to the larger NWBO longs, or to mental health, and definitely not smart either. It is like pulling out one's once-in-a-lifetime unicorn company investment, or at the very least an asymmetric investment opportunity to the upside, and throwing that into a musical chairs game. We are so close to approval. How close no one knows. But when the music stops (approval) there will be no shares to buy back at anywhere near today's prices.
Continue to BS, gaslight and mislead as always. There are quite a few pre revenue biotech that continue upwards trajectory in terms of share price because they are able to execute relentlessly and build strong confidence in the investment community. They build a compelling business narrative and are able to present that crisply to institutional investors. This management team cant even control whats in their hands which is to apply to multiple regulators as well as submit reimbursement evidence 4 years since data lock. Market makers are preventing them from submitting reimbursement evidence or applying in other jurisdictions.
Market Data 
Markets 
AI
